Related Experiment Video
Updated: Jul 10, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Economic analysis alongside clinical trials. Revisiting the methodological issues
1University of York.
International Journal of Technology Assessment in Health Care
|January 1, 1991
Summary
Integrating economic evaluations with controlled clinical trials offers valuable insights into healthcare intervention effectiveness. This paper addresses key methodological challenges in trial design, data collection, and result interpretation for robust economic analysis.
Area of Science:
- Health Economics
- Clinical Trials
- Health Services Research
Background:
- Controlled clinical trials (CCTs) are the gold standard for assessing healthcare intervention efficacy.
- Economic evaluations rely heavily on the quality of medical evidence from clinical trials.
- Integrating economic analysis into CCTs presents unique methodological challenges.
Purpose of the Study:
- To identify and discuss methodological issues arising from the integration of economic evaluations within controlled clinical trials.
- To provide guidance for economic analysts conducting evaluations alongside clinical trials.
Main Methods:
- Discussion of methodological issues in trial design for economic evaluations.
- Examination of data collection strategies for resource use and outcome data.
- Analysis of challenges in interpreting and extrapolating economic results from clinical trials.
Main Results:
- Identified critical methodological issues in trial design, data collection, and result interpretation for integrated economic evaluations.
- Highlighted the need for specific guidelines for economic analysts working with clinical trials.
Conclusions:
- The integration of economic evaluations into CCTs requires careful consideration of methodological aspects.
- Adherence to suggested guidelines can improve the quality and reliability of economic analyses conducted alongside clinical trials.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Introduction to Epidemiology
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...